Literature DB >> 30649347

Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome.

Daniel A Dumesic1, Julia D Phan1, Karen L Leung1, Tristan R Grogan2, Xiangmiang Ding3, Xinmin Li3, Luis R Hoyos1, David H Abbott4, Gregorio D Chazenbalk1.   

Abstract

CONTEXT: Normal-weight women with polycystic ovary syndrome (PCOS) may have adipose tissue insulin resistance (adipose-IR).
OBJECTIVE: To examine whether adipose-IR and subcutaneous (SC) abdominal adipose stem cell (ASC) gene expression are altered in normal-weight women with PCOS and correlated with hyperandrogenemia and/or whole-body IR.
DESIGN: Prospective cohort study.
SETTING: Academic medical center. PATIENTS: Ten normal-weight women with PCOS and 18 control subjects matched for age and body mass index. INTERVENTION(S): Women underwent circulating hormone and metabolic measurements, IV glucose tolerance testing, total-body dual-energy x-ray absorptiometry, and SC abdominal fat biopsy. MAIN OUTCOME MEASURE(S): Adipose-IR (fasting insulin × total fatty acid levels) and SC abdominal ASC gene expression were compared between groups and correlated with clinical outcomes.
RESULTS: Adipose-IR was greater in women with PCOS than in control subjects (P < 0.01), with 29 pmol/L × mmol/L providing 94% specificity and 80% sensitivity in discriminating the two groups (P < 0.001). Adipose-IR positively correlated with serum androgen and log of fasting triglyceride (TG) levels, percentage of small adipocytes (P < 0.01, all correlations), and acute insulin response to glucose (P < 0.05); and negatively correlated with insulin sensitivity (Si; P < 0.025) and serum adiponectin levels (P < 0.05). Adjusting for serum androgens, adipose-IR correlations with Si and log TG levels remained significant. ASC genes were differentially expressed by the two groups. Expression of functionally critical genes was associated with serum testosterone and/or fasting insulin levels.
CONCLUSION: Normal-weight women with PCOS have increased adipose-IR and altered ASC gene expression related to hyperandrogenism and IR.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30649347      PMCID: PMC6482023          DOI: 10.1210/jc.2018-02086

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  56 in total

Review 1.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation.

Authors:  Joel R Eisner; Daniel A Dumesic; Joseph W Kemnitz; Ricki J Colman; David H Abbott
Journal:  Obes Res       Date:  2003-02

3.  Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling.

Authors:  Anne Corbould; Young-Bum Kim; Jack F Youngren; Celia Pender; Barbara B Kahn; Anna Lee; Andrea Dunaif
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-12-21       Impact factor: 4.310

4.  Screening women with polycystic ovary syndrome for metabolic syndrome.

Authors:  Anuja Dokras; Melinda Bochner; Elizabeth Hollinrake; Sanford Markham; Bradley Vanvoorhis; Dinesh H Jagasia
Journal:  Obstet Gynecol       Date:  2005-07       Impact factor: 7.661

5.  Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.

Authors:  David A Ehrmann; David R Liljenquist; Kristen Kasza; Ricardo Azziz; Richard S Legro; Mahmoud N Ghazzi
Journal:  J Clin Endocrinol Metab       Date:  2005-10-25       Impact factor: 5.958

6.  Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women.

Authors:  A Corbould
Journal:  J Endocrinol       Date:  2007-03       Impact factor: 4.286

7.  Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.

Authors:  Teimuraz Apridonidze; Paulina A Essah; Maria J Iuorno; John E Nestler
Journal:  J Clin Endocrinol Metab       Date:  2004-12-28       Impact factor: 5.958

8.  Heterogeneity in the relationship between ethnicity, BMI, and fasting insulin.

Authors:  Latha P Palaniappan; Mercedes R Carnethon; Stephen P Fortmann
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

9.  Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function.

Authors:  Lisa Choy; Rik Derynck
Journal:  J Biol Chem       Date:  2003-01-09       Impact factor: 5.157

10.  Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein.

Authors:  Hitoshi Nishizawa; Iichiro Shimomura; Ken Kishida; Norikazu Maeda; Hiroshi Kuriyama; Hiroyuki Nagaretani; Morihiro Matsuda; Hidehiko Kondo; Naoki Furuyama; Shinji Kihara; Tadashi Nakamura; Yoshihiro Tochino; Tohru Funahashi; Yuji Matsuzawa
Journal:  Diabetes       Date:  2002-09       Impact factor: 9.461

View more
  22 in total

1.  Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary Perspective.

Authors:  Daniel A Dumesic; David H Abbott; Smriti Sanchita; Gregorio D Chazenbalk
Journal:  Curr Opin Endocr Metab Res       Date:  2020-03-09

2.  Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell Function.

Authors:  Uche Ezeh; Ida Y-D Chen; Yen-Hao Chen; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

Review 3.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

4.  Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect?

Authors:  Mojca Jensterle; Nika Aleksandra Kravos; Vita Dolžan; Katja Goričar; Rok Herman; Manfredi Rizzo; Andrej Janež
Journal:  Endocrine       Date:  2021-11-10       Impact factor: 3.633

Review 5.  Mechanisms of intergenerational transmission of polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Luis R Hoyos; Gregorio D Chazenbalk; Rajanigandha Naik; Vasantha Padmanabhan; David H Abbott
Journal:  Reproduction       Date:  2020-01       Impact factor: 3.906

Review 6.  Developmental programming of insulin resistance: are androgens the culprits?

Authors:  Muraly Puttabyatappa; Robert M Sargis; Vasantha Padmanabhan
Journal:  J Endocrinol       Date:  2020-06       Impact factor: 4.286

7.  Androgen Receptors in Multiple Organ Systems Provide Molecular Gateways to Polycystic Ovary Syndrome.

Authors:  David H Abbott; Jon E Levine; Daniel A Dumesic
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

8.  Individual and combined effects of 5-year exposure to hyperandrogenemia and Western-style diet on metabolism and reproduction in female rhesus macaques.

Authors:  Cecily V Bishop; Diana Takahashi; Emily Mishler; Ov D Slayden; Charles T Roberts; Jon Hennebold; Cadence True
Journal:  Hum Reprod       Date:  2021-01-25       Impact factor: 6.918

9.  Association of severity of menstrual dysfunction with hyperinsulinemia and dysglycemia in polycystic ovary syndrome.

Authors:  U Ezeh; M D Pisarska; R Azziz
Journal:  Hum Reprod       Date:  2022-03-01       Impact factor: 6.918

10.  Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Ayli Tulberg; Karen L Leung; Samantha C Fisch; Tristan R Grogan; David H Abbott; Rajanigandha Naik; Gregorio D Chazenbalk
Journal:  Fertil Steril       Date:  2020-12-17       Impact factor: 7.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.